YTHDF2 and hepatocellular carcinoma: According to our in vitro results, HBV infection or OGA inhibitor TMG treatment promoted HCC progression by upregulating YTHDF2 O-GlcNAcylation, whereas the OGT inhibitor OSMI-1 had the opposite effect.